We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quality Systems Deemed Inadequate at Medhab
Quality audits were not being performed at sufficient intervals, and management with executive responsibility had not reviewed the effectiveness of the quality system at defined intervals, the FDA said following an inspection of MedHab’s Arlington, Texas plant.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor